Inspire Medical Systems, Inc. reported $899M of revenue over the trailing twelve months, +4.3% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $899M (to Q2 2026). Net income: $135M, trailing twelve months to Q2 2026. Free cash flow: $117M, trailing twelve months to Q2 2026. Operating margin: 5.2%, trailing twelve months to Q2 2026.

INSPInspire Medical Systems, Inc.

Healthcare

$68.91-14% 1Y

$68.91

$40.0552 weeks$143.99

INSP as reported

Inspire Medical Systems, Inc. reported $899M of revenue over the trailing twelve months, +4.3% on the year before. 11 reported series are charted on this page, each one as filed.

$899M

Revenue, trailing twelve months · to Q2 2026 · +4.3% against the twelve months before

Net income: $135M
Net income · +154% year on year · trailing twelve months to Q2 2026
Free cash flow: $117M
Free cash flow · +38% year on year · trailing twelve months to Q2 2026
Operating margin: 5.2%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for INSP, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$899M	+4.3%	Q2 2026
Net income	$135M	+154%	Q2 2026
EPS	$4.54	+162%	Q2 2026
Gross margin	86%	n/a	Q2 2026
Operating margin	5.2%	n/a	Q2 2026
Net margin	12%	n/a	Q2 2026
ROE	15%	n/a	Q2 2026
ROA	13%	n/a	Q2 2026
ROIC	−70%	n/a	Q4 2022 · 14 quarters behind
Free cash flow	$117M	+38%	Q2 2026
P/E	15.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.